Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 506365 | NSE Symbol : | ISIN : INE320M01019 | Industry : Pharmaceuticals - Indian - Bulk Drugs |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
08-Apr-2025	16-Apr-2025	Change in Directors	Chemo Pharma Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/04/2025 inter alia to consider and approve Appointment of Directors and Resignation appointment of Company Secretary and Compliance Officer and resignation board meeting intimation attach. OUTCOME OF THE BOARD MEETING HELD ON WEDNESDAY, APRIL 16, 2025 (As Per BSE Announcement Dated on: 16/04/2025) Reply to email dated 23/04/2025 regarding Additional detail required for Corporate Announcement filed under Regulation 30 of SEBI (LODR) Regulation 2015 (As Per BSE Announcement dated on 23.04.2025)
13-Jan-2025	27-Jan-2025	Quarterly Results	CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2025 inter alia to consider and approve the following businesses:- 1. To consider and approve the Un-Audited Financial Results for the quarter and nine months ended December 31 2024 along with the Limited Review Report. 2. Appointment of S K JAIN & Co. Membership No. 1473 and COP No. 3076 Company Secretaries as a Secretarial Auditor of the Company for the Financial Year 2024-25. Approved the Un-Audited Financial Results for the Quarter and Nine Months Ended December 31, 2024 2. Approved the Appointment of M/s S K Jain & Co. Practicing Company Secretary as the Secretarial Auditor of the Company for the Financial Year 2024-25. (As Per BSE Announcement Dated on: 27.01.2025)
15-Oct-2024	28-Oct-2024	Quarterly Results	CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2024 inter alia to consider and approve the Un-Audited Financial Statements for the quarter and half year ended September 30 2024 along with the Limited Review Report thereon. Approval of Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2024 along with the Limited Review Report thereon. (As Per BSE Announcement Dated on: 28/10/2024)
09-Jul-2024	29-Jul-2024	Quarterly Results	CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2024 inter alia to consider and approve the following business: 1. To consider and approve the Un-Audited Financial Results for the quarter ended June 30 2024 along with the Limited Review Report thereon. 2. To consider and approve the Notice of the 82nd Annual General Meeting of the Company to be held on Monday September 23 2024 at 04:00 p.m. at the Registered Office of the Company at 5-Kumud Apartment Co. op. Hsg. Soc. Ltd. Karnik Road Chikan Ghar Kalyan Dist. Thane- 421301 for the year ended March 31 2024. 3. To consider and fix Book Closure along with Record Date for the forthcoming Annual General Meeting of the Company. 4. To approve appointment of CS Hemant Shetye Designated Partner of HSPN & Associates LLP Company Secretaries to act as a Scrutinizer for the forthcoming 82nd Annual General Meeting of the Company. 1. Approval of Un-Audited Financial Results of the Company for the quarter ended June 30, 2024 along with the Limited Review Report thereon. 2. Approval of the Notice of the 82nd Annual General Meeting of the Company to be held on Monday, September 23, 2024 at 04:00 p.m. at the Registered Office of the Company at 5-Kumud Apartment Co. op. Hsg. Soc. Ltd., Karnik Road, Chikan Ghar, Kalyan, Dist. Thane- 421301 for the year ended March 31, 2024. 3. Approval of Book Closure date from September 17, 2024 to September 23, 2024 (both days inclusive) and Record Date will be September 16, 2024. 4. Appointment of CS Hemant Shetye, Designated Partner of HSPN & Associates LLP, Company Secretaries, to act as a Scrutinizer for the forthcoming 82nd Annual General Meeting of the Company. (As per BSE Announcement Dated on 29/07/2024)
10-May-2024	27-May-2024	Accounts	CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2024 inter alia to consider and approve the following business: 1. To consider and approve the Audited Financial Results for the quarter and year ended March 31 2024 along with the Auditors Report thereon. 2. To consider appointment of M/s Sarda Soni & Associates as Internal Auditor of the Company for the financial year 2024-25 Outcome Of The Board Meeting Held On Monday, May 27, 2024 Audited Financial Results of the Company for the Quarter and Year Ended March 31, 2024 Appointment of M/S Sarda Soni Associates LLP as an Internal Auditor for the Financial Year 2024-2025 (As Per BSE Announcement Dated on 27.05.2024)
09-Jan-2024	29-Jan-2024	Quarterly Results	CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2024 inter alia to consider and approve 1. the Un-Audited Financial Statement for the quarter and nine months ended December 31 2023 along with the Limited Review Report. 2.Re-Appointment of M/s Kavita Khatri & Associates Company Secretaries as a Secretarial Auditor of the Company for the Financial Year 2023-24. 1. Approval the Un-Audited Financial Results of the Company for the quarter and nine months ended December 31, 2023 along with the Limited Review Report thereon. 2. Approved the Appointment of M/s Kavita Khatri & Associates Company Secretary as the Secretarial Auditor of the Company for the Financial Year 2023-24. Approval the Un-Audited Financial Results of the Company for the quarter and nine months ended December 31, 2023 along with the Limited Review Report thereon. (As Per BSE Announcement Dated on 29/01/2024)
16-Oct-2023	27-Oct-2023	Quarterly Results	CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2023 inter alia to consider and approve the Un-Audited Financial Statements for the quarter and half year ended September 30 2023 along with the Limited Review Report thereon. Approval of Un-Audited Financial Results for the Quarter and Half Year Ended September 30, 2023 along with the Limited Review Report thereon. Approval of Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2023 along with the Limited Review Report thereon. (As per BSE Announcement Dated on 27/10/2023)
14-Jul-2023	27-Jul-2023	Quarterly Results	CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2023 inter alia to consider and approve 1. the Un-Audited Financial Results for the quarter ended June 30 2023 along with the Limited Review Report thereon. 2. To consider and approve the Notice of the 81st Annual General Meeting of the Company to be held on Monday September 25 2023 at 04:00 p.m. at the Registered Office of the Company at 5-Kumud Apartment Co. op. Hsg. Soc. Ltd. Karnik Road Chikan Ghar Kalyan Dist. Thane- 421301 for the year ended March 31 2023. 3. To consider and fix Book Closure along with Record Date for the forthcoming Annual General Meeting of the Company. 4. To approve appointment of CS Hemant Shetye Designated Partner of HSPN & Associates LLP Company Secretaries to act as a Scrutinizer for the forthcoming 81st Annual General Meeting of the Company. Approval of Un-Audited Financial Results of the Company for the Quarter Ended June 30, 2023 along with the Limited Review Report thereon. (As Per BSE Announcement dated on 27.07.2023)
15-May-2023	24-May-2023	Change in Auditors	CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2023 inter alia to consider and approve 1. To consider and approve the Audited Financial Results for the quarter and year ended March 31 2023 along with the Auditors Report thereon. 2. To consider appointment of M/s Sarda Soni & Associates as Internal Auditor of the Company for the financial year 2023-24 3. To consider appointment of Company Secretary and Compliance Officer of the Company. Outcome of the Board Meeting held on May 24, 2023 Appointment of M/s. Sarda Soni Associates LLP as an Internal Auditor for the Financial Year 2023-2024 (As Per BSE Announcement Dated on 24.05.2023)
05-Jan-2023	31-Jan-2023	Quarterly Results	CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2023 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday January 31 2023 at 04:00 p.m. at the Corporate Office of the Company inter alia to consider and approve the Un-Audited Financial Statement for the quarter and nine months ended December 31 2022 along with the Limited Review Report. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we wish to inform you that the Board of Directors of the Company at their meeting held today, i.e. January 31, 2023, approved the Un-Audited Financial Results of the Company for the quarter and nine months ended December 31, 2022 along with the Limited Review Report thereon. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we wish to inform you that the Board of Directors of the Company at their meeting held today, i.e. January 31, 2023, approved the Un-Audited Financial Results of the Company for the quarter and nine months ended December 31, 2022 along with the Limited Review Report thereon. (As Per BSE Announcement Dated on 31.01.2023)
21-Dec-2022	26-Dec-2022	Change in Other Executives	CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/12/2022 inter alia to consider and approve 1. To take on record Resignation of Ms. Neha Vora Company Secretary and Compliance Officer of the Company; 2. Re-appointment of M/s Kavita Khatri & Associates Company Secretaries as the Secretarial Auditor of the Company for the financial year 2022-23; 3. Any other matter with the permission of chair. 1. Considered and approved the resignation of Ms. Neha Vora as a Company Secretary and Compliance Officer of the Company with effect from December 15, 2022; 2. Approved the appointment of M/s Kavita Khatri & Associates, Company Secretaries as the Secretarial Auditor of the Company for the financial year 2022-23; and 3. Approved the appointment of Mr. Ashok Somani, Director as Compliance Officer of the Company with effect from December 26, 2022. Appointment of Mr. Ashok Somani, Director as Compliance Officer of the Company with effect from December 26, 2022. (As per BSE Announcement Dated on 26/12/2022)
13-Oct-2022	20-Oct-2022	Quarterly Results	CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/10/2022 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company will be held on Thursday October 20 2022 at 04:00 p.m. at the Corporate Office situated at Empire House 214 Dr. D.N. Road Fort Mumbai - 400 001 inter alia to consider and approve the Un-Audited Financial Statements for the quarter and half year ended September 30 2022 along with the Limited Review Report thereon. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we wish to inform you that the Board of Directors of the Company at their meeting held today, i.e. October 20, 2022, approved the Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2022 along with the Limited Review Report thereon. We are enclosing herewith, a copy of the Un-Audited Financial Results for the quarter and half year ended September 30, 2022 along with the Limited Review Report thereon by the auditor and cash flow statement and statement of assets and liabilities for the half year ended on 30th September, 2022. The Meeting commenced at 04.00 p.m. and concluded at 04.55 p.m. Approval of Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2022 along with the Limited Review Report thereon. (As Per BSE Announcement Dated on 20/10/2022)
20-Jul-2022	28-Jul-2022	Quarterly Results	CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2022 inter alia to consider and approve 1. To consider and approve the Un-Audited Financial Results for the quarter ended June 30 2022 along with the Limited Review Report thereon. 2. To consider and approve the Notice of the 80th Annual General Meeting of the Company to be held on Thursday September 08 2022 at 04:00 p.m. at the Registered Office of the Company at 5-Kumud Apartment Co. op. Hsg. Soc. Ltd. Karnik Road Chikan Ghar Kalyan Dist. Thane- 421301 for the year ended March 31 2022. 3. To consider and fix Book Closure along with Record Date for the forthcoming Annual General Meeting of the Company. 4. To approve appointment of CS Hemant Shetye Designated Partner of HSPN & Associates LLP Company Secretaries to act as a Scrutinizer for the forthcoming 80th Annual General Meeting of the Company. 1. Approval of Un-Audited Financial Results of the Company for the quarter ended June 30, 2022 along with the Limited Review Report thereon. 2. Approval of the Notice of the 80th Annual General Meeting of the Company to be held on Thursday, September 08, 2022 at 04:00 p.m. at the Registered Office of the Company at 5-Kumud Apartment Co. op. Hsg. Soc. Ltd., Karnik Road, Chikan Ghar, Kalyan, Dist. Thane- 421301 for the year ended March 31, 2022. 3. Approval of Book Closure date from September 02, 2022 to September 08, 2022 (both days inclusive) and Record Date will be September 01, 2022. 4. Appointment of CS Hemant Shetye, Designated Partner of HSPN & Associates LLP, Company Secretaries, to act as a Scrutinizer for the forthcoming 80th Annual General Meeting of the Company. Approval of Un-Audited Financial Results of the Company for the quarter ended June 30, 2022 along with the Limited Review Report thereon. (As Per BSE Announcement dated on 28.07.2022)
17-May-2022	27-May-2022	Accounts	CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2022 inter alia to consider and approve 1. To consider and approve the Audited Financial Results for the quarter and year ended March 31 2022 along with the Auditors Report thereon. 2. To consider and appoint M/s Sarda Soni & Associates as Internal Auditor of the Company for the financial year 2022-23 Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we wish to inform you that the Board of Directors of the Company at their meeting held today, i.e. May 27, 2022, have discussed the following matters: 1. Approval of Audited Standalone Financial Results of the Company for the quarter and year ended March 31, 2022 along with the Statutory Auditor's Report thereon. The Audit Reports were issued with unmodified opinion of the financial statements. 2. Appointment of M/s. Sarda Soni Associates LLP as an Internal Auditor for the Financial Year 2022-2023. 3. Approval of Draft Report of Board of Directors, Management Discussion & Analysis Report along with other supporting documents forming part of Annual Report for the financial year 2021-22. 4. Considered and took on record Secretarial Audit Report issued by M/s Kavita Khatri & Associates, Practicing Company Secretary. (As per BSE Announcement Dated on 27/05/2022)
13-Jan-2022	28-Jan-2022	Quarterly Results	CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2022 inter alia to consider and approve the Un-Audited Financial Results for the quarter and nine months ended 31st December 2021 along with the Limited Review Report thereon and appoint Secretarial Auditor of the Company for the Financial Year 2021-2022 Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we wish to inform you that the Board of Directors of the Company at their meeting held today, i.e. January 28, 2022, have discussed the following matters: 1. Approval of Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2021 along with the Limited Review Report thereon. 2. Appointment of M/s. Kavita Khatri & Associates as an Secretarial Auditor for the Financial Year 2021-2022. (As Per BSE Announcement Dated on 28.01.2022)

1 2

LOGIN HERE

Chemo Pharma Laboratories Ltd

Board Meeting